{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T19:19:51Z","timestamp":1789154391498,"version":"build-2803163510"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"vor","delay-in-days":44,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine Case Reports"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/j.rmcr.2025.102181","type":"journal-article","created":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T21:26:25Z","timestamp":1739654785000},"page":"102181","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Efficacy and safety of lenvatinib in a case of thymic carcinoma complicated with interstitial lung disease and anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis: A case report"],"prefix":"10.1016","volume":"54","author":[{"given":"Yuki","family":"Hatakeyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4333-8100","authenticated-orcid":false,"given":"Jun","family":"Sakakibara-Konishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Tarumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosuke","family":"Tsuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megumi","family":"Furuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Takashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidenori","family":"Kitai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuaki","family":"Shoji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyuki","family":"Ikezawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Konno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmcr.2025.102181_bib1","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1016\/j.ejca.2011.08.008","article-title":"Rare cancers are not so rare: the rare cancer burden in Europe","volume":"47","author":"Gatta","year":"2011","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.rmcr.2025.102181_bib2","doi-asserted-by":"crossref","first-page":"e668","DOI":"10.1634\/theoncologist.2019-0593","article-title":"Clinical outcomes of second-line chemotherapy in patients with previously treated advanced thymic carcinoma: a retrospective analysis of 191 patients from the NEJ023 study","volume":"25","author":"Tateishi","year":"2020","journal-title":"Oncologist"},{"key":"10.1016\/j.rmcr.2025.102181_bib3","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S1470-2045(20)30162-5","article-title":"Lenvatinib in patients with advanced or metastatic thymic carcinoma (remora): a multicentre, phase 2 trial","volume":"21","author":"Sato","year":"2020","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.rmcr.2025.102181_bib4","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.lungcan.2020.08.014","article-title":"North East Japan Study Group. Prognostic factors for patients with metastatic or recurrent thymic carcinoma receiving palliative-intent chemotherapy","volume":"148","author":"Okuma","year":"2020","journal-title":"Lung Cancer"},{"key":"10.1016\/j.rmcr.2025.102181_bib5","doi-asserted-by":"crossref","first-page":"5501","DOI":"10.21873\/anticanres.17376","article-title":"Key therapeutic agents for thymic carcinoma in real-world clinical practice","volume":"44","author":"Tateishi","year":"2024","journal-title":"Anticancer Res."},{"key":"10.1016\/j.rmcr.2025.102181_bib6","first-page":"75","article-title":"A case of squamous cell carcinoma of unknown primary that responded to the multi-tyrosine kinase inhibitor lenvatinib, Case Rep","volume":"11","author":"Kimura-Tsuchiya","year":"2018","journal-title":"Oncol."},{"key":"10.1016\/j.rmcr.2025.102181_bib7","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s12328-019-00983-x","article-title":"Interstitial pneumonia suspected during regorafenib administration and exacerbated by subsequent therapy with lenvatinib for unresectable hepatocellular carcinoma","volume":"12","author":"Kotani","year":"2019","journal-title":"Clin. J. Gastroenterol."},{"key":"10.1016\/j.rmcr.2025.102181_bib8","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.2169\/internalmedicine.7300-21","article-title":"Lenvatinib-induced interstitial pneumonia in a patient with hepatocellular carcinoma","volume":"61","author":"Imakura","year":"2022","journal-title":"Intern. Med."},{"key":"10.1016\/j.rmcr.2025.102181_bib9","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1056\/NEJMc1008506","article-title":"Interstitial lung disease and gefitinib","volume":"363","author":"Murashige","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.rmcr.2025.102181_bib10","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0140-6736(03)12190-3","article-title":"Severe acute interstitial pneumonia and gefitinib","volume":"361","author":"Inoue","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.rmcr.2025.102181_bib11","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1183\/09031936.01.00074701","article-title":"Vascular endothelial growth factor synthesis in the acute phase of experimental and clinical lung injury","volume":"18","author":"Maitre","year":"2001","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmcr.2025.102181_bib12","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1164\/ajrccm.164.9.2011071","article-title":"Vascular endothelial growth factor may contribute to increased vascular permeability in acute respiratory distress syndrome","volume":"164","author":"Thickett","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmcr.2025.102181_bib13","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.rmed.2016.02.001","article-title":"Nintedanib in patients with idiopathic pulmonary fibrosis: combined evidence from the TOMORROW and INPULSIS(\u00ae) trials","volume":"113","author":"Richeldi","year":"2016","journal-title":"Respir. Med."},{"key":"10.1016\/j.rmcr.2025.102181_bib14","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1016\/j.cllc.2017.06.003","article-title":"Treatment rationale and design for J-SONIC: a randomized study of carboplatin plus nab-paclitaxel with or without nintedanib for advanced non-small-cell lung cancer with idiopathic pulmonary fibrosis","volume":"19","author":"Otsubo","year":"2018","journal-title":"Clin. Lung Cancer"},{"key":"10.1016\/j.rmcr.2025.102181_bib15","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1054\/bjoc.2001.1699","article-title":"Risk of cancer in patients with dermatomyosistis or polymyositis, and follow-up implications: a Scottish population-based cohort study","volume":"85","author":"Stockton","year":"2001","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.rmcr.2025.102181_bib16","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.rmed.2016.10.019","article-title":"Comprehensive assessment of myositis-specific autoantibodies in polymyositis\/dermatomyositis-associated interstitial lung disease","volume":"121","author":"Hozumi","year":"2016","journal-title":"Respir. Med."},{"key":"10.1016\/j.rmcr.2025.102181_bib17","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s11748-012-0144-x","article-title":"Paraneoplastic dermatomyositis as presentation of thymic carcinoma","volume":"61","author":"Dell'Amore","year":"2013","journal-title":"Gen. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.rmcr.2025.102181_bib18","article-title":"Anti-TIF1\u03b3 antibody predicted malignancy of thymic tumor with dermatomyositis as an \"autoimmune tumor marker\": a case report","volume":"97","author":"Karino","year":"2018","journal-title":"Med. (Baltim.)."},{"key":"10.1016\/j.rmcr.2025.102181_bib19","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00595-007-3601-x","article-title":"Successful resection of dermatomyositis associated with thymic carcinoma: report of a case","volume":"38","author":"Takahashi","year":"2008","journal-title":"Surg. Today."},{"key":"10.1016\/j.rmcr.2025.102181_bib20","doi-asserted-by":"crossref","first-page":"292","DOI":"10.11604\/pamj.2015.21.292.6887","article-title":"Dermatomyosite amyopathique r\u00e9v\u00e9lant un carcinome thymique [Amyopathic dermatomyositis revealing a thymic carcinoma]","volume":"21","author":"Ma Mahfoudhi","year":"2015","journal-title":"Pan Afr. Med. J."},{"key":"10.1016\/j.rmcr.2025.102181_bib21","doi-asserted-by":"crossref","first-page":"e247","DOI":"10.1016\/j.athoracsur.2019.07.039","article-title":"Paraneoplastic dermatomyositis as a potential precursor to thymic carcinoma","volume":"109","author":"Tsuchiya","year":"2020","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.rmcr.2025.102181_bib22","first-page":"2031","article-title":"Successful treatment of thymic carcinoma with dermatomyositis and interstitial pneumonia: a case report, Thorac","volume":"10","author":"Yang","year":"2019","journal-title":"Cancer."},{"key":"10.1016\/j.rmcr.2025.102181_bib23","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1093\/rheumatology\/kes102","article-title":"Anti-MDA5 antibody, ferritin and IL-18 are useful for the evaluation of response to treatment in interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis","volume":"51","author":"Gono","year":"2012","journal-title":"Rheumatol. (Oxf. Engl.)."},{"key":"10.1016\/j.rmcr.2025.102181_bib24","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1136\/ard.59.4.257","article-title":"Sequential changes of KL-6 in sera of patients with interstitial pneumonia associated with polymyositis\/dermatomyositis","volume":"59","author":"Bandoh","year":"2000","journal-title":"Ann. Rheum. Dis."}],"container-title":["Respiratory Medicine Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213007125000176?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213007125000176?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T17:16:56Z","timestamp":1747243016000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213007125000176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":24,"alternative-id":["S2213007125000176"],"URL":"https:\/\/doi.org\/10.1016\/j.rmcr.2025.102181","relation":{},"ISSN":["2213-0071"],"issn-type":[{"value":"2213-0071","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of lenvatinib in a case of thymic carcinoma complicated with interstitial lung disease and anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis: A case report","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmcr.2025.102181","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102181"}}